CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2003-10-31): Innocent bystander mechanism behind hepatocyte injury in HCV/HIV coinfection

Science

Innocent bystander mechanism behind hepatocyte injury in HCV/HIV coinfection

Last Updated: 2003-10-31 14:56:03 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Hepatic injury in hepatitis C virus (HCV) and HIV coinfection may not result from viral infection per se, according to a report in the October 15th issue of The Journal of Infectious Diseases.

"We hypothesized that hepatocytes exposed to HIV and HCV virions might be subjected to signaling effects produced by the binding of virus proteins to the cell surface, independent of cell infection and viral replication within the cell," the authors explain.

To test this hypothesis, Dr. Jerome E. Groopman and colleagues from Harvard Institutes of Medicine and Beth Israel Deaconess Medical Center in Boston, Massachusetts, developed an in vitro model of HCV/HIV coinfection using nanomolar concentrations of HCV E2 and HIV gp120 proteins.

HCV E2 and HIV gp120 bound to the surface of HepG2 cells and primary hepatocytes and induced apoptosis at concentrations well within the ranges seen during clinical infection, the authors report. The apoptotic effects seen with both proteins were synergistic rather than simply additive.

Blocking the CXCR4 surface receptor reduced apoptosis by about 42%, the report indicates, confirming the role of CXCR4 in the signaling effects leading to apoptosis.

Treatment of cells with the two viral proteins induced the expression of the pro-apoptotic Fas ligand and induced dephosphorylation and modest degradation of the anti-apoptotic AKT protein, the researchers note.

"Here, we provide evidence that suggests that HCV and HIV envelope proteins, at physiological concentrations, can have deleterious effects on hepatocytes via a unique pathway of collaborative signaling," the authors conclude.

"Therapeutic strategies designed to protect 'innocent bystander' hepatocytes from the cooperative effects of HIV and HCV binding may serve to limit the progressive liver disease seen in persons coinfected with HIV and HCV," the investigators add.

J Infect Dis 2003;188:1192-1204.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.